Effects Of PF-02545920 On Ketamine-Induced Abnormal Prefrontal Brain Response To Associative Learning In Healthy Subjects

PHASE1TerminatedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions
Healthy
Interventions
OTHER

Saline

Saline infusion for 56 minutes

DRUG

PF-02545920

PF-02545920 10 mg single dose

OTHER

Ketamine

"Ketamine 0.23 mg/kg bolus over one min; and 0.58 mg/kg/hour maintenance for 56 minutes~PF-02545920 10 mg tablet"

DRUG

PF-02545920

PF-02545920 10 mg tablet single dose

OTHER

Saline

Saline infusion for 56 minutes

OTHER

Placebo

Placebo tablet single dose

OTHER

Ketamine

Ketamine 0.23 mg/kg bolus over one min; and 0.58 mg/kg/hour maintenance for 56 minutes

OTHER

Placebo

Placebo tablet single dose

Trial Locations (3)

06510

Pfizer Investigational Site, New Haven

06519

Pfizer Investigational Site, New Haven

06520

Pfizer Investigational Site, New Haven

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY